MARKET

SNY

SNY

Sanofi FR
NASDAQ
48.27
+0.44
+0.92%
Pre Market: 48.44 +0.17 +0.35% 06:37 02/10 EST
OPEN
47.83
PREV CLOSE
47.83
HIGH
48.45
LOW
47.66
VOLUME
10.17K
TURNOVER
0
52 WEEK HIGH
57.58
52 WEEK LOW
44.62
MARKET CAP
117.50B
P/E (TTM)
12.85
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SNY last week (0202-0206)?
Weekly Report · 1d ago
Sanofi's Rilzabrutinib Wayrilz Granted FDA Breakthrough Therapy Designation In The US And Orphan Drug Status In Japan For Treatment Of Warm Autoimmune Hemolytic Anemia
Benzinga · 1d ago
Sanofi’s rilzabrutinib gains breakthrough therapy status in US, orphan drug designation in Japan
Seeking Alpha · 1d ago
BRIEF-Sanofi Says Rilzabrutinib Designated Breakthrough Therapy In US
Reuters · 1d ago
Sanofi erhält FDA-Breakthrough-Therapie-Status für Rilzabrutinib zur Behandlung von wAIHA
Reuters · 1d ago
Sanofi’s Rilzabrutinib Wins FDA Breakthrough Therapy Status for Rare Anemia
Reuters · 1d ago
Oakmark International Strategy Q4 2025 New Investments And Divestments
Seeking Alpha · 1d ago
Sanofi Wins Positive EU CHMP Opinion for Rezurock in Chronic Graft-Versus-Host Disease
TipRanks · 3d ago
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.